1 |
Toskich B, Vidal LL, Olson MT, Lewis JT, LeGout JD, Sella DM, Montazeri SA, Devcic Z, Lewis AR, Frey GT, Ritchie CA, Paz-Fumagalli R, Croome KP, Patel TC. Pathologic Response of Hepatocellular Carcinoma Treated with Yttrium-90 Glass Microsphere Radiation Segmentectomy Prior to Liver Transplantation: A Validation Study. J Vasc Interv Radiol 2021;32:518-526.e1. [PMID: 33551304 DOI: 10.1016/j.jvir.2020.12.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
2 |
Toskich BB, Muneer MS, Gopal N, Akinduro OO, Marenco-Hillembrand L, Ritchie C, Miller DA, Middlebrooks EH, Tawk RG. Mapping angiography and transarterial technetium macroaggregated albumin particle simulation of recurrent atypical intracranial meningioma: feasibility for potential vascular brachytherapy. Radiol Case Rep 2020;15:2278-81. [PMID: 32983300 DOI: 10.1016/j.radcr.2020.07.051] [Reference Citation Analysis]
|
3 |
Ahmed A, Stauffer JA, LeGout JD, Burns J, Croome K, Paz-Fumagalli R, Frey G, Toskich B. The use of neoadjuvant lobar radioembolization prior to major hepatic resection for malignancy results in a low rate of post hepatectomy liver failure. J Gastrointest Oncol 2021;12:751-61. [PMID: 34012663 DOI: 10.21037/jgo-20-507] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Gordon AC, Gabr A, Riaz A, Uddin OM, Abouchaleh N, Ali R, Kallini J, Salem R, Lewandowski RJ. Radioembolization Super Survivors: Extended Survival in Non-operative Hepatocellular Carcinoma. Cardiovasc Intervent Radiol 2018;41:1557-65. [PMID: 29948005 DOI: 10.1007/s00270-018-2008-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
|
5 |
Entezari P, Gabr A, Salem R, Lewandowski RJ. Yttrium-90 for colorectal liver metastasis - the promising role of radiation segmentectomy as an alternative local cure. International Journal of Hyperthermia 2022;39:620-6. [DOI: 10.1080/02656736.2021.1933215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
6 |
Devcic Z, Elboraey M, Vidal L, Mody K, Harnois D, Patel T, Toskich BB. Individualized Ablation of Hepatocellular Carcinoma: Tailored Approaches across the Phenotype Spectrum. Semin Intervent Radiol 2019;36:287-97. [PMID: 31680719 DOI: 10.1055/s-0039-1698755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
7 |
Syed M, Shah J, Montazeri SA, Grajo JR, Geller B, Toskich B. Analysis of dynamic hepatobiliary contrast-enhanced MRI signal intensity after Yttrium-90 radioembolization with glass microspheres for the treatment of hepatocellular carcinoma. Abdom Radiol 2021;46:2182-7. [DOI: 10.1007/s00261-020-02855-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
8 |
Baker T, Tabrizian P, Zendejas I, Gamblin TC, Kazimi M, Boudjema K, Geller D, Salem R. Conversion to resection post radioembolization in patients with HCC: recommendations from a multidisciplinary working group. HPB (Oxford) 2022;24:1007-18. [PMID: 35012876 DOI: 10.1016/j.hpb.2021.12.013] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|